Dietary Supplements and Middle Aged Women (Collagen & Omega)
The Effects of Dietary Supplements on Health and Wellbeing in Middle Aged Women
Loughborough University
34 participants
May 1, 2026
INTERVENTIONAL
Conditions
Summary
This study will examine the effects of combining different types of dietary supplements on various aspects of health and wellbeing in middle aged women. The main outcomes of the trial will be aspects of health and wellbeing that middle aged women report as increasingly problematic, such as joint pain, fatigue, sleep, and changes in body composition, strength, and inflammation. Participants will consume the supplement(s) or placebo for 8 weeks, and outcome measures will be assessed before and after supplementation.
Eligibility
Inclusion Criteria6
- Female
- Age 35 - 65 years old
- Healthy, free from known disease
- Non-smoker
- BMI of 18 - 30 kg/m2 of
- Classified as either recreationally physically active (meet the WHO guidelines for physical activity of completing at least 150-300 min moderate-intensity activity or 75-150 min of vigorous-intensity activity a week, plus muscle-strengthening activities 2 or more days a week) OR classified as sedentary (do not meet minimum activity guidelines but do occasional and/or incidental physical activity (e.g., walking to work, household activities))
Exclusion Criteria10
- Currently have a musculoskeletal injury or diagnosed condition (e.g., cardiovascular disease, osteoarthritis, diabetes, cancer, metabolic syndrome, uncontrolled hypertension, gastrointestinal disease, blood clotting disorder)
- Regularly taking prescription medication initiated in the last 3 months or unstable
- Have initiated hormone replacement therapy within the last 3 months and/or currently unstable
- BMI not between 18-30 kg/m2
- Allergy to ingredients in supplements or standardized breakfasts
- Pregnant or breastfeeding, or any other contraindications to consuming study supplements
- Lost more than 10% of body mass in past 6 months or plan on trying to lose body mass during trial period
- Currently consuming the supplements being investigated and unwilling to stop taking them
- Any known cognitive or visual impairments limiting ability to perform cognitive tests
- Unwilling to maintain current diet and physical activity levels or exercise and activity levels above recreationally active (e.g., athlete)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Collagen peptides daily for 8 weeks (\~10 g/day) Omega-3 supplement daily for 8 weeks (2 capsules/day)
Maltodextrin (\~10 g/day) for 8 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07740967